Lv51
980 积分 2021-08-16 加入
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
18天前
已完结
Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China
19天前
已完结
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial
3个月前
已完结
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer
3个月前
已关闭
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
3个月前
已完结
Effect of BRAFV600E and TERT Promoter Mutations on Thyroglobulin Response in Patients With Distant-Metastatic Differentiated Thyroid Cancer
1年前
已完结
Prevalence of Postoperatively Detected High-risk Features in 2- to 4-cm Papillary Thyroid Cancers
1年前
已完结
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
1年前
已完结
Advances in tests for colorectal cancer screening and diagnosis
1年前
已完结
皖公网安备34019202002308
